Globus Medical, Inc. (GMED) financial statements and ratios from SEC XBRL: revenue $2.94B (TTM), net margin 18.3%, revenue growth 5.9% YoY, P/E 21.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.94B |
| Net Margin | 18.3% |
| Revenue Growth (YoY) | 5.9% |
| EPS Growth (YoY) | -25.3% |
| FCF Growth (YoY) | 464.1% |
| P/E Ratio | 21.5 |
| EV / EBITDA | 12.0 |
| Price / Book | 2.41 |
| Price / Sales | 3.66 |
| FCF Yield | 6.6% |
| DCF Value (model) | $51.69 |
| DCF Upside vs Price | -39.7% |
| Altman Z-Score | 11.12 (safe) |
| Sector P/E (Healthcare) | 21.6 |
GMED overview · GMED earnings · GMED KPIs · GMED investor relations · GMED ownership · GMED peers · GMED filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.